Chongqing Zhifei Biological Products has been in the biological products industry since 2002.
Chongqing Zhifei Biological Products employs 4500 people and it was listed on Shenzhen Stock Exchange in 2010.
The company’s vaccines are mainly for human use. The company has won many awards for its pioneering work in vaccine development.
Read More:
Chongqing Zhifei Biological Products worked with the Institute of Microbiology of Chinese Academy of Sciences to develop the novel coronavirus vaccine.
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd is a wholly-owned subsidiary of Chongqing Zhifei Biological Products. The company is focused on research, development and sales of vaccines.
Anhui Zhifei Longcom Biopharmaceutical Co Ltd is another wholly-owned subsidiary of Chongqing Zhifei Biological Products. The company owns a factory which sits on 216,282 square meters. It produces vaccines for TB, influenza, norovirus and rabies among others.
Logistics and warehousing centers
Chongqing Zhifei Biological Products has invested in warehouses and logistics centers in China. They deliver with 48 to 72 hours.
Zhifei Airport International Trading Co Ltd also a wholly-owned subsidiary of Chongqing Zhifei Biological Products is responsible for customs clearance as well as registration of imported vaccines as efficiently as possible.
End
